177 related articles for article (PubMed ID: 37563360)
1. B-type Plexins promote the GTPase activity of Ran to affect androgen receptor nuclear translocation in prostate cancer.
Garg R; Endzhievskaya S; Williamson M
Cancer Gene Ther; 2023 Nov; 30(11):1513-1523. PubMed ID: 37563360
[TBL] [Abstract][Full Text] [Related]
2. PlexinB1 Promotes Nuclear Translocation of the Glucocorticoid Receptor.
Williamson M; Garg R; Wells CM
Cells; 2019 Dec; 9(1):. PubMed ID: 31861264
[TBL] [Abstract][Full Text] [Related]
3. Function of mutant and wild-type plexinb1 in prostate cancer cells.
Damola A; Legendre A; Ball S; Masters JR; Williamson M
Prostate; 2013 Sep; 73(12):1326-35. PubMed ID: 23775445
[TBL] [Abstract][Full Text] [Related]
4. Plexin-B1 signalling promotes androgen receptor translocation to the nucleus.
Williamson M; de Winter P; Masters JR
Oncogene; 2016 Feb; 35(8):1066-72. PubMed ID: 25982277
[TBL] [Abstract][Full Text] [Related]
5. HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain.
Deng Q; Luo L; Quan Z; Liu N; Du Z; Sun W; Luo C; Wu X
Mol Med Rep; 2019 Mar; 19(3):2115-2124. PubMed ID: 30664187
[TBL] [Abstract][Full Text] [Related]
6. ARA24/Ran enhances the androgen-dependent NH2- and COOH-terminal interaction of the androgen receptor.
Harada N; Ohmori Y; Yamaji R; Higashimura Y; Okamoto K; Isohashi F; Nakano Y; Inui H
Biochem Biophys Res Commun; 2008 Aug; 373(3):373-7. PubMed ID: 18565325
[TBL] [Abstract][Full Text] [Related]
7. Effect of cancer-associated mutations in the PlexinB1 gene.
Zhou C; Wong OG; Masters JR; Williamson M
Mol Cancer; 2012 Mar; 11():11. PubMed ID: 22404908
[TBL] [Abstract][Full Text] [Related]
8. Plexin-B1 plays a redundant role during mouse development and in tumour angiogenesis.
Fazzari P; Penachioni J; Gianola S; Rossi F; Eickholt BJ; Maina F; Alexopoulou L; Sottile A; Comoglio PM; Flavell RA; Tamagnone L
BMC Dev Biol; 2007 May; 7():55. PubMed ID: 17519029
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor splice variants activate androgen receptor target genes and support aberrant prostate cancer cell growth independent of canonical androgen receptor nuclear localization signal.
Chan SC; Li Y; Dehm SM
J Biol Chem; 2012 Jun; 287(23):19736-49. PubMed ID: 22532567
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
Xie Y; Wolff DW; Lin MF; Tu Y
Mol Pharmacol; 2007 Jul; 72(1):73-85. PubMed ID: 17430995
[TBL] [Abstract][Full Text] [Related]
11. MED19 alters AR occupancy and gene expression in prostate cancer cells, driving MAOA expression and growth under low androgen.
Weber H; Ruoff R; Garabedian MJ
PLoS Genet; 2021 Jan; 17(1):e1008540. PubMed ID: 33513133
[TBL] [Abstract][Full Text] [Related]
12. In vitro gene expression changes of androgen receptor coactivators after hormone deprivation in an androgen-dependent prostate cancer cell line.
Chang HC; Chen SC; Chen J; Hsieh JT
J Formos Med Assoc; 2005 Sep; 104(9):652-8. PubMed ID: 16276440
[TBL] [Abstract][Full Text] [Related]
13. Vav3, a Rho GTPase guanine nucleotide exchange factor, increases during progression to androgen independence in prostate cancer cells and potentiates androgen receptor transcriptional activity.
Lyons LS; Burnstein KL
Mol Endocrinol; 2006 May; 20(5):1061-72. PubMed ID: 16384856
[TBL] [Abstract][Full Text] [Related]
14. TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth.
Daniels G; Li Y; Gellert LL; Zhou A; Melamed J; Wu X; Zhang X; Zhang D; Meruelo D; Logan SK; Basch R; Lee P
Endocr Relat Cancer; 2014 Feb; 21(1):127-42. PubMed ID: 24243687
[TBL] [Abstract][Full Text] [Related]
15. Elevated LIM kinase 1 in nonmetastatic prostate cancer reflects its role in facilitating androgen receptor nuclear translocation.
Mardilovich K; Gabrielsen M; McGarry L; Orange C; Patel R; Shanks E; Edwards J; Olson MF
Mol Cancer Ther; 2015 Jan; 14(1):246-58. PubMed ID: 25344584
[TBL] [Abstract][Full Text] [Related]
16. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.
Sadar MD; Gleave ME
Cancer Res; 2000 Oct; 60(20):5825-31. PubMed ID: 11059779
[TBL] [Abstract][Full Text] [Related]
17. The adrenal androgen androstenediol is present in prostate cancer tissue after androgen deprivation therapy and activates mutated androgen receptor.
Mizokami A; Koh E; Fujita H; Maeda Y; Egawa M; Koshida K; Honma S; Keller ET; Namiki M
Cancer Res; 2004 Jan; 64(2):765-71. PubMed ID: 14744796
[TBL] [Abstract][Full Text] [Related]
18. The Hsp90 inhibitor, 17-AAG, prevents the ligand-independent nuclear localization of androgen receptor in refractory prostate cancer cells.
Saporita AJ; Ai J; Wang Z
Prostate; 2007 Apr; 67(5):509-20. PubMed ID: 17221841
[TBL] [Abstract][Full Text] [Related]
19. ING3 promotes prostate cancer growth by activating the androgen receptor.
Nabbi A; McClurg UL; Thalappilly S; Almami A; Mobahat M; Bismar TA; Binda O; Riabowol KT
BMC Med; 2017 May; 15(1):103. PubMed ID: 28511652
[TBL] [Abstract][Full Text] [Related]
20. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A
Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
